IXIARO
IC51-325
Phase 3 mab completed
Quick answer
IXIARO for Japanese Encephalitis is a Phase 3 program (mab) at Valneva Austria GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Valneva Austria GmbH
- Indication
- Japanese Encephalitis
- Phase
- Phase 3
- Modality
- mab
- Status
- completed